Simoctocog Alfa Effective, Safe in Children With Severe Hemophilia A
Data from recent studies published in Therapeutic Advances in Hematology show that simoctocog alfa both prevents and treats bleeding in children with severe hemophilia A, with low rates of inhibitor development.1 Findings from 2 prospective, open-label, …